113
Participants
Start Date
February 27, 2024
Primary Completion Date
November 30, 2026
Study Completion Date
January 31, 2027
Onvansertib
Oral capsule
FOLFIRI
FOLFIRI (irinotecan + fluorouracil \[5-FU\] + leucovorin) as intravenous (IV) infusion
Bevacizumab
IV Infusion
FOLFOX
FOLFOX (leucovorin + fluorouracil \[5-FU\] + oxaliplatin) as intravenous (IV) infusion
Manhattan Hematology Oncology (MHO) Research Foundation, Inc., New York
Lehigh Valley Health Network, Allentown
Inova Schar Cancer Institute, Fairfax
University of Virginia, Charlottesville
VCU Massey Cancer Center, Richmond
Mayo Clinic - Florida, Jacksonville
Memorial Cancer Institute, Hollywood
Cleveland Clinic Martin Health, Stuart
West Cancer Clinic, Germantown
The Ohio State University Wexner Medical Center, Columbus
University Hospitals Cleveland Medical Center, Cleveland
Cleveland Clinic, Cleveland
Trihealth Kenwood, Cincinnati
Fort Wayne Medical Oncology and Hematology, Fort Wayne
Cancer & Hematology Centers of Western Michigan - Lemmen-Holton Cancer Pavilion, Grand Rapids
ThedaCare Regional Cancer Center, Appleton
Mayo Clinic Cancer Center, Rochester
Washington University School of Medicine Center for Advanced Medicine, St Louis
Saint Luke's Hospital, Kansas City
The University of Kansas Cancer Center - Westwood, Westwood
Cancer Center of Kansas, Wichita
St. Bernards Medical Center, Jonesboro
Highlands Oncology Group, Springdale
Oncology Consultants, PA, Houston
MD Anderson Cancer Center, Houston
Utah Cancer Specialists, Salt Lake City
Mayo Clinic - Arizona, Phoenix
The University of Arizona Cancer Center, Tucson
CCCN, Las Vegas
Norris Comprehensive Cancer Center, Los Angeles
UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Torrance Memorial Physician Network - Cancer Care and Infusion Center, Torrance
PIH Health, Whittier
UC San Diego Moores Cancer Center, La Jolla
Sharp Memorial Hospital, San Diego
Orange Coast Memorial Medical Center, Fountain Valley
Pacific Cancer Medical Center, Anaheim
Comprehensive Blood and Cancer Center - Bakersfield, Bakersfield
Kaiser Permanente, Honolulu
Oregon Health and Science University, Portland
Virginia Mason Medical Center, Seattle
Lead Sponsor
Collaborators (1)
Pfizer
INDUSTRY
Cardiff Oncology
INDUSTRY